Xingbo Mo
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
-
- Diabetes Management and Research
- Diabetes Management and Education
Papers in
-
- Cancer-related molecular mechanisms research 18
-
- RNA modifications and cancer 18
- Cancer-related gene regulation 9
- Epigenetics and DNA Methylation 7
- RNA Research and Splicing 5
- Co-authors
- Shu‐Feng Lei (42 shared papers)Dongfeng Gu (10 shared papers)Yonghong Zhang (10 shared papers)Jianfeng Huang (5 shared papers)Xueli Yang (3 shared papers)Jie Cao (2 shared papers)Xiaohua Liang (1 shared paper)Fei‐Yan Deng (23 shared papers)
- Journals
- PLoS ONE (4 papers)Epigenomics (3 papers)European Heart Journal (2 papers)Journal of Cellular and Molecular Medicine (2 papers)Lara D. Veeken (2 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Xingbo Mo
72 papers receiving 2.1k citations
Xingbo Mo's Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 291
- Endocrinology, Diabetes and Metabolism 230
- Rheumatology 178
- Genetics 318
- Molecular Biology 705
Countries citing papers authored by Xingbo Mo
This map shows the geographic impact of Xingbo Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingbo Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingbo Mo more than expected).
Fields of papers citing papers by Xingbo Mo
This network shows the impact of papers produced by Xingbo Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingbo Mo. The network helps show where Xingbo Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xingbo Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis Hit paper breakdown → | 2010 | 431 |
| 2 | 2012 | 268 | |
| 3 | 2014 | 168 | |
| 4 | 2022 | 119 | |
| 5 | 2018 | 88 | |
| 6 | 2022 | 57 | |
| 7 | 2014 | 53 | |
| 8 | 2012 | 51 | |
| 9 | 2019 | 48 | |
| 10 | 2018 | 46 | |
| 11 | 2018 | 42 | |
| 12 | 2019 | 42 | |
| 13 | 2016 | 38 | |
| 14 | 2012 | 35 | |
| 15 | 2010 | 32 | |
| 16 | 2018 | 30 | |
| 17 | 2018 | 28 | |
| 18 | 2015 | 27 | |
| 19 | 2011 | 27 | |
| 20 | 2018 | 25 |
About Xingbo Mo
Xingbo Mo is a scholar working on Cancer Research, Molecular Biology, Genetics, Rheumatology and Cardiology and Cardiovascular Medicine, having authored 79 papers that have together received 2.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (18 papers), Cancer-related molecular mechanisms research (18 papers), Genetic Associations and Epidemiology (13 papers), Cancer-related gene regulation (9 papers), Epigenetics and DNA Methylation (7 papers), RNA Research and Splicing (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). The work is most often cited by research in Cancer Research (291 citations), Endocrinology, Diabetes and Metabolism (230 citations), Rheumatology (178 citations), Genetics (318 citations) and Molecular Biology (705 citations). Xingbo Mo has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Shu‐Feng Lei, Dongfeng Gu, Yonghong Zhang, Jianfeng Huang, Xueli Yang, Jie Cao, Xiaohua Liang, Fei‐Yan Deng, Huan Zhang and Long‐Fei Wu. Their work appears in journals such as PLoS ONE, Epigenomics, European Heart Journal, Journal of Cellular and Molecular Medicine and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.